Cure enters this GSL Season 2 Group Stage BO3 holding strong recent form as a top Terran, with consistent results against elite competition including playoff runs and series wins over players like Rogue and Trigger. sOs, a veteran Protoss, has shown inconsistency, including a straight-sets loss to Maru and a prior 0-2 defeat to Cure in the same tournament cycle. Head-to-head history favors Cure in the TvP matchup, where his aggressive early-game strategies and map control have repeatedly disrupted sOs's timing attacks and macro transitions. Patch adjustments to Terran-Protoss dynamics and sOs's limited recent offline success further tilt trader consensus toward Cure's implied probability edge in this group stage encounter.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoCure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Mercado abierto: May 19, 2026, 6:00 PM ET
Fuente de resolución
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure vs sOs
Moneyline
$110 Vol.
Map 1 Winner
$816 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Mercado abierto: May 19, 2026, 6:00 PM ET
Fuente de resolución
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure enters this GSL Season 2 Group Stage BO3 holding strong recent form as a top Terran, with consistent results against elite competition including playoff runs and series wins over players like Rogue and Trigger. sOs, a veteran Protoss, has shown inconsistency, including a straight-sets loss to Maru and a prior 0-2 defeat to Cure in the same tournament cycle. Head-to-head history favors Cure in the TvP matchup, where his aggressive early-game strategies and map control have repeatedly disrupted sOs's timing attacks and macro transitions. Patch adjustments to Terran-Protoss dynamics and sOs's limited recent offline success further tilt trader consensus toward Cure's implied probability edge in this group stage encounter.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoCuidado con los enlaces externos.
Cuidado con los enlaces externos.


Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes